BIAGX
Price
$14.79
Change
+$0.20 (+1.37%)
Updated
Apr 11 closing price
Net Assets
577.03M
RGAGX
Price
$67.32
Change
+$1.06 (+1.60%)
Updated
Apr 11 closing price
Net Assets
260.89B
Ad is loading...

BIAGX vs RGAGX

Header iconBIAGX vs RGAGX Comparison
Open Charts BIAGX vs RGAGXBanner chart's image
Brown Advisory Growth Equity I
Price$14.79
Change+$0.20 (+1.37%)
VolumeN/A
Net Assets577.03M
American Funds Growth Fund of Amer R6
Price$67.32
Change+$1.06 (+1.60%)
VolumeN/A
Net Assets260.89B
BIAGX vs RGAGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BIAGX vs. RGAGX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIAGX is a Buy and RGAGX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 261B vs. BIAGX (577M). RGAGX pays higher dividends than BIAGX: RGAGX (0.71) vs BIAGX (0.00). BIAGX was incepted earlier than RGAGX: BIAGX (26 years) vs RGAGX (16 years). BIAGX (0.84) is less costly to investors than RGAGX (0.30). BIAGX is a more actively managed with annual turnover of: 33.00 vs. RGAGX (25.00). BIAGX has a lower initial minimum investment than RGAGX: BIAGX (100) vs RGAGX (250). RGAGX annual gain was more profitable for investors over the last year : -4.89 vs. BIAGX (-48.88). RGAGX return over 5 years is better than : 49.17 vs. BIAGX (-39.61).
BIAGXRGAGXBIAGX / RGAGX
Total Expense Ratio0.840.30280%
Annual Report Gross Expense Ratio0.840.30280%
Fund Existence26 years16 years-
Gain YTD-11.683-9.698120%
Front LoadN/AN/A-
Min. Initial Investment10025040%
Min. Initial Investment IRAN/AN/A-
Net Assets577M261B0%
Annual Yield % from dividends0.000.71-
Returns for 1 year-48.88-4.89999%
Returns for 3 years-47.487.71-616%
Returns for 5 years-39.6149.17-81%
Returns for 10 years-28.0652.69-53%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYRA0.100.02
+20.38%
Lyra Therapeutics
NUVB1.990.24
+13.71%
Nuvation Bio
VTRS7.540.28
+3.86%
Viatris
ELMD22.53-0.06
-0.27%
Electromed
APPN27.02-0.23
-0.84%
Appian Corp